title: Multipoint analysis of human chromosome 11p15/mouse distal chromosome 7: inclusion of H19/IGF2 in the minimal WT2 region, gene specificity of H19 silencing in Wilms' tumorigenesis and methylation hyper-dependence of H19 imprinting.
abstract: WT2 is defined by maternal-specific loss of heterozygosity (LOH) on chromosome 11p15.5 in Wilms' tumors (WTs). The imprinted H19 gene, in this region, is silenced and hypermethylated in most WTs, and this is linked to pathological biallelic expression of IGF2. However, H19 and IGF2 lie within a larger imprinted domain, and the gene specificity of H19 epimutation has been a persistent question. To address this, we assessed LOH, gene expression and DNA methylation at multiple sites in and around the imprinted domain. LOH mapping showed that the entire domain, including IGF2/H19, is within the minimal WT2 region. Genes within the domain, including IPL/TSSC3/BWR1C, IMPT1/ORCTL2/BWR1A/TSSC5, KvLQT1/KCNA9 and TAPA1/CD81, as well as the zinc finger gene ZNF195/ZNFP104 near the centromeric border, were expressed persistently in many WTs. DNA hypermethylation was not detected with 5" upstream probes for IPL, IMPT1, KvLQT1 and ZNF195 in WTs or WT-associated kidneys. Fully developed WTs showed variable hypomethylation at an imprinted CpG island in a KvLQT1 intron, but this was only complete in the cases with LOH and was not observed in pre-neoplastic WT-associated kidneys with H19 epimutation. Analysis of the corresponding region of mouse chromosome 7 using methyltransferase-hypomorphic mice showed that the H19 imprint was fully erased, but that the allelic bias at Ipl, Impt1, p57 Kip2 and, to a lesser extent, Kvlqt1, persisted. Pre-existing massive allelic asymmetry for DNA methylation and hyper-dependence of transcription on methylation status may underlie the mechanism of gene-specific silencing of H19 in Wilms' tumorigenesis.
authors.affiliation: Department of Pathology and Institute for Cancer Genetics, Columbia Univesity College of Physicians and Surgeons, New York, NY 10032, USA.
authors.forename: D
authors.initials: D
authors.lastname: Dao
authors.forename: C P
authors.initials: CP
authors.lastname: Walsh
authors.forename: L
authors.initials: L
authors.lastname: Yuan
authors.forename: D
authors.initials: D
authors.lastname: Gorelov
authors.forename: L
authors.initials: L
authors.lastname: Feng
authors.forename: T
authors.initials: T
authors.lastname: Hensle
authors.forename: P
authors.initials: P
authors.lastname: Nisen
authors.forename: D J
authors.initials: DJ
authors.lastname: Yamashiro
authors.forename: T H
authors.initials: TH
authors.lastname: Bestor
authors.forename: B
authors.initials: B
authors.lastname: Tycko
mesh_terms: D000818:Animals; D002874:Chromosome Mapping; D002880:Chromosomes, Human, Pair 11; D019175:DNA Methylation; D016162:Genes, Wilms Tumor; D018392:Genomic Imprinting; D006801:Humans; D007335:Insulin-Like Growth Factor II / Q000235:genetics; D007668:Kidney / Q000503:physiopathology; D019656:Loss of Heterozygosity; D051379:Mice; D009124:Muscle Proteins / Q000096:biosynthesis / Q000235:genetics*; D062085:RNA, Long Noncoding; D012334:RNA, Neoplasm / Q000096:biosynthesis; D022661:RNA, Untranslated; D009396:Wilms Tumor / Q000209:etiology / Q000235:genetics*
chemical_list: C094335:H19 long non-coding RNA; D009124:Muscle Proteins; D062085:RNA, Long Noncoding; D012334:RNA, Neoplasm; D022661:RNA, Untranslated; D007335:Insulin-Like Growth Factor II